Health Summit Asia (HSA) will return from 5 to 7 May 2027 at the KL Convention Centre, under the theme “One Ecosystem. One Pulse. Shaping the Future of Health Economy.”
The event comes at a pivotal moment. Asia’s healthcare market is projected to reach US$5 trillion (RM20 trillion) by 2030, driven by a rapidly ageing population. Asia is already home to 60% of the world’s population aged 65 and above, and UNESCAP estimates that the Asia-Pacific 60+ demographic will double from 670 million in 2022 to 1.3 billion by 2050. This demographic shift makes sustainable healthcare delivery increasingly urgent—particularly in Malaysia, which the World Bank projects will become an aged society by 2044 (14% aged 65+) and a super-aged society by 2056 (20%+).
Speaking at the soft launch, Yang Berhormat Dato’ Hajjah Hanifah Hajar Taib, Deputy Minister of Health, Malaysia, said: “HSA 2027 aligns with Malaysia’s national healthcare goals and public-private health strategies. It reflects an important truth about healthcare today: progress can no longer happen in silos. It requires concerted and collaborative effort across government, healthcare providers, industry, academia, investors, innovators, and the wider health economy. By convening these great minds from across the region, I believe HSA will contribute meaningfully to building a society that is healthier, more productive, and more resilient.”
To accelerate real market impact, HSA 2027 is introducing Market Access Clinics, a signature practical route-to-market programme designed to help international and regional delegates translate opportunity into a structured Malaysia and Asia market-entry plan.
Taking place on 7 May, Market Access Clinics will use focused small-group sessions to explore the intricacies of entering Malaysia’s healthcare market across three core topics:
- Regulation: Navigating regulatory frameworks, evidence expectations, and compliance before committing resources.
- Hospital Adoption: Demonstrating clinical relevance, workflow fit, economic feasibility, and implementation readiness to healthcare providers.
- Distribution Partnerships: Identifying, evaluating, and structuring commercial agreements with ideal distribution partners.
Richard Teo, Executive Chairman of Qube Integrated Malaysia, said: “The industry is at an important inflection point; we must break down boundaries and forge partnerships that will allow us to take strides in moving the healthcare industry beyond a narrow clinical sector into a full-scale growth economy encompassing care delivery, digital infrastructure, AI, and preventive wellness. HSA 2027 will be the platform to do this, reading the pulse of the industry at a regional level, congregating changemakers, and converting high-level conversations directly into commercial action.”
HSA 2027 aims to attract 120 exhibitors from 10 countries. The event will feature five core pillars: a two-day conference, a trade exhibition, market access clinics, an industry spotlight, and B2B meetings. It is expected to draw exhibitors and delegates from over 60 countries, with exhibitors spanning digital health and technology, medical devices and consumables, pharmaceutical innovation, nutrition and nutraceuticals, as well as health policy and regulation.
The conference will feature key discussions and critical industry insights from leading minds in the sector. Day one is themed Asia’s Health Economy – Markets, Policy, Capital and Technology, covering topics such as The Silver Economy: Where Demand and Capital Are Moving and Funding the Health Economy: What Capital Will Back in 2027.
Day two is themed From Market Access to Better Health – Commercialisation, Medicine and Wellness, featuring topics such as From Approval to Adoption: Winning Buyers and Distribution Channels Across ASEAN and The Next Operating Theatre: Robotics, Image-Guided Surgery and Minimally Invasive Care.
Confirmed speakers and panelists include Dato’ Dr. Kuljit Singh, President, Association of Private Hospitals Malaysia; Dr. Kamal Amzan, CEO, IHH Healthcare Malaysia; Ivin Yew, CEO, General Health Services, Doctor Anywhere Singapore; Dr. Jacob Choi, CTO, Samsung Medical Centre, South Korea; Proud Patavianich, Assistant CEO, MedPark Hospital Bangkok, Thailand; Professor Patrick Tan, Dean, Duke-NUS Medical School Singapore & Executive Director, Precision Health Research Singapore; Professor Yoshihiro Muragaki, Professor, Department of Medical Device Engineering, Kobe University Japan; and Gertrude Ting, General Manager, Medical Devices, DKSH Malaysia and Honorary Treasurer, Malaysia Medical Device Association.
Kevin Teo, Deputy Managing Director, Qube Integrated Malaysia and Show Director, HSA 2027, said: “HSA 2027 will serve as Asia’s premier business and market-intelligence platform to convert market shifts into actionable economic and clinical outcomes. We have taken great care to structure the upcoming event to offer more than brand visibility, focusing on qualified B2B leads, targeted matchmaking, and direct route-to-market decisions. I invite all members of the vibrant healthcare ecosystem to join us on this journey towards HSA 2027.”
HSA 2027 is organised by Qube Integrated Malaysia with the support of the Ministry of Health Malaysia. As part of its expanding roster of partners, HSA 2027 welcomes the Malaysian Pharmacists Society and the Malaysian Medical Association as Supporting Partners, as well as the National Council of Women’s Organisation (NCWO), Malaysia, and VNU Asia Pacific as Strategic Partners.
Health Summit Asia takes place from 5 to 7 May 2027 at the KL Convention Centre. For more information, visit https://healthsummitasia.com/. To book a space at the trade exhibition, visit https://reg.healthsummitasia.com/book-a-space/. For other enquiries, contact vimeitaygm@qube.com.my.
